MedTrace Logo

Chemotherapy and Tumor Clearance in Hepatic Resections for Colorectal Liver Metastases.

NCT05273489 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 170

Last updated 2022-03-10

No results posted yet for this study

Summary

Retrospective analysis of a prospectively collected database of 170 patients between 2004 and 2020, who underwent liver resections for CRLM (colorectal liver metastases) at The Queen Elizabeth Hospital trying to determine rates and patterns of recurrence following liver resections for CRLM and concurrently, characterise clinical, pathological and treatment-related factors that could function as predictors of recurrence or survival, particularly neoadjuvant chemotherapy and tumour clearance.

Conditions

  • Colorectal Cancer Metastatic
  • Liver Metastases

Interventions

PROCEDURE

Hepatectomy

Neoadjuvant treatment

Sponsors & Collaborators

  • University of Adelaide

    collaborator OTHER

  • Hospital Maciel

    lead OTHER

Principal Investigators

  • Mauro A Perdomo, MD, MHA · Assitant Professor at Clinica Quirurgica 3. Universidad de la Republica. Monteviedo, Uruguay

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-01-01
Primary Completion
2020-12-31
Completion
2021-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05273489 on ClinicalTrials.gov